Webinar: Optimized Culture Conditions and Potency Testing Workflows to Support the Development of Cellular Therapies Using CRISPR-Cas Edited CD34+ Cells
December – Cellular Therapy topic
Webinar Date: Tuesday, December 15, 2020 06:00 PM
Standardized culture conditions are key to maintaining primitive hematopoietic cells in culture, and achieving efficient genome editing. We will discuss key considerations when developing optimized workflows for the in vitro culture of primative CD34+ cell populations, genome editing, and the importance of potency testing for manipulated cell therapy products.
Amanda Fentiman, MSc
Product Manager, Hematology
STEMCELL Technologies, Inc.
Vancouver, British Columbia
This webinar is approved for 1.0 credit hours by the ASCLS P.A.C.E. ® Program.
For a recording of this presentation, click below and enter Passcode: AtE=0nD6
November – Transfusion Medicine topic
Webinar Date: Tuesday, November 17, 2020 6:00pm
Human leukocyte antigens (HLA) form the basis of immunology and our ability to recognize self versus non-self. By differentiating our cells from altered cells and pathogens, our immune system works to protect us. It is an amazing system.
Carolyn T. Young, MD
Medical Director, Histocompatibility Laboratory
Rhode Island Hospital
For a recording of this webinar, click below and enter Access Passcode: .=Z.1VnP
October – Cellular Therapy topic
Webinar Date: Tuesday 10/20/20 at 6:00pm
Laertis Ikonomou, PhD
Associate Professor, Department of Oral Biology
University at Buffalo, SUNY
There are hundreds of cell, tissue, and gene products at various stages of preclinical and clinical development worldwide. At the same time, a multifaceted industry that offers direct-to-consumer, unproven, and untested cell products and services has emerged. The ensuing ethical, scientific, and regulatory issues will be discussed.
For a recording of this presentation, click below and enter Access Passcode: k22$!QJ.
September – Transfusion Medicine topic
Webinar Date: Tuesday 9/22/20 at 6:00pm
Walter “Sunny” Dzik, MD
Co-Director, Blood Transfusion Service
Massachusetts General Hospital
This presentation will summarize the growing conceptual framework for understanding the effect of severe COVID-19 infection on patients. COVID infection demonstrates the well-known intersection of inflammation and thrombosis and offers new opportunities to study the role of vascular endothelium and complement biology in hemostasis.
A video recording of this webinar is available upon request. Contact email@example.com.
MABB is proud to partner with our fellow professional organizations to bring you more opportunities for continuing education.
Email us at firstname.lastname@example.org to add your continuing education opportunity to our website.
MABB is an approved provider of P.A.C.E. Credits by the ASCLS P.A.C.E. ® Program.